Bl 30 - analogs
Prices in pharmacies: Instructions Bl 30 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Losartan Sandoz ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 36% Sp 12 neutral
- 34% Bl 55 neutral
- 30% Bl 31 neutral
- 25% Bl 27 neutral
- 25% Gb 28 neutral
- 24% St 28 neutral
- 24% Gb 27 neutral
- 23% Liv 9 neutral
- 23% Bl 26 neutral
- 22% Bl 38 neutral
- 22% St 30 neutral
- 22% St 29 neutral
- 21% Bl 61 neutral
- 21% Liv 6 neutral
- 21% Bl 47 neutral
- 21% Bl 34 neutral
- 20% PC147 Чжи-чжуань-цзинь neutral
- 19% Kid 8 neutral
- 19% Bl 53 neutral
- 19% PC70 Чжу-чжан neutral
- 19% Kid 13 neutral
- 19% Bl 32 neutral
- 17% Sp 8 neutral
- 17% Si 6 neutral
- 17% Bl 52 neutral
- 16% Sp 10 neutral
- 16% Gb 25 neutral
- 16% Ren 5 neutral
- 16% Bl 28 neutral
- 16% Kid 11 neutral
- 16% Kid 12 neutral
- 16% Bl 46 neutral
- 15% Tb 4 neutral
- 15% Bl 62 neutral
- 15% Ren 2 neutral
- 14% Bl 54 neutral
- 14% St 32 neutral
- 14% Si 16 neutral
- 14% PC48 Чан-и neutral
- 14% Bl 29 neutral
- 14% Bl 5 neutral
- 13% Kid 10 neutral
- 13% Bl 25 neutral
- 13% Bl 37 neutral
- 13% Bl 42 neutral
- 13% L.i. 13 neutral
- 13% PC66 Пи-гэнь neutral
- 12% Kid 14 neutral
- 12% Ren 1 neutral
- 12% Liv 8 neutral
Learn more about the selection of analogues
- The drug has «Bl 30» no complete analogues; 51 analog by action, the most similar - Sp 12 .
- Medical online service has selected the best substitutes for Bl 30 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Bl 30 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.